[go: up one dir, main page]

BR0208146A - Uso de propentofilina para controlar pressão intra-ocular - Google Patents

Uso de propentofilina para controlar pressão intra-ocular

Info

Publication number
BR0208146A
BR0208146A BR0208146-6A BR0208146A BR0208146A BR 0208146 A BR0208146 A BR 0208146A BR 0208146 A BR0208146 A BR 0208146A BR 0208146 A BR0208146 A BR 0208146A
Authority
BR
Brazil
Prior art keywords
propentophylline
intraocular pressure
control intraocular
control
pressure
Prior art date
Application number
BR0208146-6A
Other languages
English (en)
Inventor
Iok-Hou Pang
Mark R Hellberg
Abbot F Clark
Peggy E Hellberg
Debra L Shade
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0208146A publication Critical patent/BR0208146A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE PROPENTOFILINA PARA CONTROLAR PRESSãO INTRA-OCULAR". São revelados métodos para o controle de pressão intra-ocular com propentofilina.
BR0208146-6A 2001-03-21 2002-02-22 Uso de propentofilina para controlar pressão intra-ocular BR0208146A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27754801P 2001-03-21 2001-03-21
PCT/US2002/005456 WO2002076460A2 (en) 2001-03-21 2002-02-22 Use of propentofylline to control intraocular pressure

Publications (1)

Publication Number Publication Date
BR0208146A true BR0208146A (pt) 2004-03-02

Family

ID=23061335

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208146-6A BR0208146A (pt) 2001-03-21 2002-02-22 Uso de propentofilina para controlar pressão intra-ocular

Country Status (7)

Country Link
EP (1) EP1370267A2 (pt)
JP (1) JP2004528310A (pt)
AR (1) AR032812A1 (pt)
BR (1) BR0208146A (pt)
CA (1) CA2434691A1 (pt)
MX (1) MXPA03008491A (pt)
WO (1) WO2002076460A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010016043A1 (en) * 2008-08-05 2010-02-11 University College Cork, National University Of Ireland, Cork Treatment of retinal degeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage

Also Published As

Publication number Publication date
JP2004528310A (ja) 2004-09-16
CA2434691A1 (en) 2002-10-03
WO2002076460A3 (en) 2003-04-03
WO2002076460A2 (en) 2002-10-03
MXPA03008491A (es) 2003-12-08
EP1370267A2 (en) 2003-12-17
AR032812A1 (es) 2003-11-26

Similar Documents

Publication Publication Date Title
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
BRPI0414539A (pt) composto, composição farmacêutica, e, uso de um composto
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
BR0308211A (pt) Cumarinas úteis como biomarcadores
ATE233274T1 (de) Oxyiminopregnancarbolactone
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
DE60137835D1 (de) Modifizierte zytokine für krebs therapie
AU2002221908A1 (en) Novel use of protein hydrolysates
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
TR200102742T2 (tr) Rezorsinol türevleri
DK1532131T3 (da) Motilid-forbindelser
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
BR0208146A (pt) Uso de propentofilina para controlar pressão intra-ocular
BR0316544A (pt) Compostos calcilìticos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 4A, 5A,6A E 7A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.